Log In
Print
BCIQ
Print
Print this Print this
 

AMG 319

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionSmall molecule inhibitor of phosphoinositide 3-kinase (PI3K) delta
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHematologic malignancies
Indication DetailsTreat hematologic malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today